“…NLRP1 is known to be an inflammasome sensor in humans. To our knowledge, certain neuropsychiatric disorders [e.g., multiple sclerosis (40), Alzheimer's disease (41), autism spectrum disorder (42), schizophrenia (43)], ophthalmic diseases [e.g., uveitis (44), corneal intraepithelial dyskeratosis (45,46)], colorectal adenomatous polyposis (47), respiratory papillomatosis (48), orthopedic diseases [e.g., rheumatoid arthritis (49)], endocrine disorders [e.g., autoimmune Addison's disease (50,51), type 1 diabetes (51)] and skin disorders [e.g., NAIAD (23), multiple selfhealing palmoplantar carcinoma (1), keratosis lichenoides chronica (1), vitiligo (50)(51)(52)(53)] have been reported as NLRP1-related diseases. Thus, NLRP1 is one of the most important molecules for various systemic disorders, including inflammatory diseases.…”